Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
BELGRADE, Mont.--(BUSINESS WIRE)--Bacterin International Holdings, Inc. (NYSE MKT: BONE), a leader in the development of revolutionary bone graft material and coatings for medical applications, today announced that it has entered into a definitive securities purchase agreement with both existing and new investors to purchase 8.51 million unregistered shares of its common stock and warrants to purchase approximately 4.25 million shares of its common stock. Upon closing, the transaction will result in gross proceeds to Bacterin International of approximately $4.85 million, before deducting placement agents’ fees and offering expenses. Proceeds from the transaction will be used to fund the Company’s operations and working capital requirements.
Help employers find you! Check out all the jobs and post your resume.
